3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
8
Withdrawn
4
Terminated
4
Unknown
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Recurrence
7
Lymphoma, Non-Hodgkin
6
Multiple Myeloma
5
Lymphoma, Large B-Cell, Diffuse
4
Hodgkin Disease
4
Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
2
Waldenstrom Macroglobulinemia
1
Small Cell Lung Carcinoma
1
Neoplasms, Plasma Cell
1
Neoplasms, Experimental
1
Neoplasms by Histologic Type
1
Lymphomatoid Granulomatosis
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Immune System Diseases
1
Burkitt Lymphoma
1
Interventions
Cytarabine
35
Cyclophosphamide
26
Etoposide
18
Radiotherapy
16
Daunorubicin
16
Busulfan
15
Peripheral Blood Stem Cell Transplantation
14
Methotrexate
14
Idarubicin
14
Mercaptopurine
12
Dexamethasone
12
Vincristine
11
Thioguanine
9
Mitoxantrone
9
Doxorubicin
8
Asparaginase
8
Antilymphocyte Serum
8
pegaspargase
7
fludarabine phosphate
7
Prednisolone
7
Polymerase Chain Reaction
7
Filgrastim
7
Cyclosporine
7
Prednisone
6
Mycophenolic Acid
5
Melphalan
5
Leucovorin
5
Gene Expression Profiling
5
Vindesine
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Leukemia
×
Bendamustine Hydrochloride
×
Clear all
NCT01657955
2012-08-06
CLL
Shandong Lanjin Pharmaceuticals Co.,Ltd
Phase 3
Unknown
96 enrolled